NCT05222269View on ClinicalTrials.gov

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

January 25, 2023

Study Completion Date

January 25, 2023

Conditions
CNS Lymphoma
Interventions
DRUG

68Ga-PTF

68Ga-PTF will be injected intravenously at three time points during the course of the standard treatment of the patient.

Trial Locations (2)

9000

University Hospital Aalborg, Aalborg

44093

University Hospital CHU Nantes, Nantes

Sponsors

Lead Sponsor

Pentixapharm AG
All Listed Sponsors
lead

Pentixapharm AG

INDUSTRY

NCT05222269 - [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients | Biotech Hunter | Biotech Hunter